The Korean drug regulatory body has issued approval to drugmaker Chong Kun Dang for its generic version of Jardiance (empagliflozin), which is expected to hit the market in October 2025. Chong Kun Dang becomes the 50th company to receive approval for generic Jardiance.
In order to make diabetes treatment affordable, the National Pharmaceutical Pricing Authority (NPPA), an Indian government regulatory agency, has capped the ceiling prices for 12 generic medicines. The medicines include glimepiride, metformin, glucose injection, and insulin.
Medical information website Medicine Net has explained how much carbs should a diabetic eat. It advises diabetics to consider getting half of their calories from carbs. For people with diabetes, keeping a check on their carb intake would help maintain steady blood sugar levels.
A new study from Danish researchers has suggested that a widely used osteoporosis drug called Fosamax (alendronate) could reduce the risk of type 2 diabetes. The study found that people who took Fosamax for at least eight years were less likely to develop type 2 diabetes.
Prof. Jianjun Guan of Washington University in St. Louis and his team have developed a hydrogel that delivers oxygen to wounds, decreasing inflammation, repairing tissue, and promoting healing. The hydrogel could specifically be useful for wounds in patients with diabetic ulcers.
In July, the FDA approved the use of Semglee, the first interchangeable biosimilar insulin product that controls diabetes. The agency said one can use Semglee instead of Lantus as a cheaper alternative, but GlobalData Healthcare says Semglee’s success will be limited due to the declining use of the first-generation long-acting insulin.
A new review from 29 studies has found that a low glycemic index diet, which is rich in vegetables, fruit, and fiber, is beneficial for people with diabetes. Researchers from the University of Toronto found that a low glycemic index diet keeps your blood sugar under control.